Generate a tailored SOP for Dr. Alanna Schepartz. Improve your application with a focused, well-structured draft.
Professor Alanna Schepartz conducts research at the intersection of chemistry and biology, focusing on Chemical Biology, Synthetic Biology, Organic Chemistry, and Biophysics. Her lab is dedicated to advancing knowledge in the chemistry-biology continuum, aiming to design and discover molecules with unique and useful properties that can revolutionize therapeutic applications and scientific understanding. Current projects in her research group include the repurposing of ribosomes to biosynthesize defined chemical polymers, improving the trafficking efficiency of therapeutic proteins into mammalian cells, and understanding how proteins encode chemical information and influence cellular processes. Schepartz's innovative work addresses critical challenges in drug delivery and signaling pathways, thereby contributing significantly to the field of chemical biology. She is an elected member of the National Academy of Sciences and has received numerous awards for her contributions, including the Ralph F. Hirschmann Award in Peptide Chemistry and the ACS Chemical Biology Prize. Additionally, Schepartz plays a pivotal role in the academic community as the Editor-in-Chief of Biochemistry.
University of California, Berkeley • Berkeley, CA
T.Z. Irmgard Chu Distinguished Chair in the Department of Chemistry and Professor in the Department of Molecular and Cell Biology.
Yale University • New Haven, CT
Held the Sterling Professorship in the Department of Chemistry.
Yale University • New Haven, CT
Led research and teaching in the field of chemistry.
Yale University • New Haven, CT
Tenured faculty member in the Department of Chemistry.
Yale University • New Haven, CT
Advanced to the rank of Associate Professor in Chemistry.
Yale University • New Haven, CT
Started academic career as an Assistant Professor in Chemistry.
Caltech • Pasadena, CA
Conducted postdoctoral research in chemistry.
The Mathematics Subject GRE is required for the Fall 2026 admissions cycle. General GRE is optional.